On September 13, 2002, WLF filed detailed comments with the Food and Drug Administration (FDA), urging FDA to modify its regulatory activities so that they no longer violate the First Amendment rights of those seeking to speak truthfully about pharmaceutical products. On October 28, 2002, WLF filed additional comments, responding to congressional Democrats and others who believe that FDA should regulate speech even more extensively.